abstract |
The present invention relates to compositions comprising inhibitors of human histone nmethyltransferase EZH2 and one or more other therapeutic agents, particularly anticancer nagents such as prednisone, and methods of combination therapy for administering to subjects nin need thereof for the treatment of cancer. See Fig. 2. |